Anti-CD44 antibody [EPR1013Y]
- RabMAb
- Recombinant
- KO Validated
- Lab Essentials
- 20ul selling size
- What is this?
3
(11 Reviews)
|
(177 Publications)
Rabbit Recombinant Monoclonal CD44 antibody. Suitable for IHC-P, WB and reacts with Human samples. Cited in 177 publications.
View Alternative Names
CD44, LHR, MDU2, MDU3, MIC4, CD44 antigen, CDw44, Epican, Extracellular matrix receptor III, GP90 lymphocyte homing/adhesion receptor, HUTCH-I, Heparan sulfate proteoglycan, Hermes antigen, Hyaluronate receptor, Phagocytic glycoprotein 1, Phagocytic glycoprotein I, ECMR-III, PGP-1, PGP-I
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD44 antibody [EPR1013Y] (AB51037)
ab51037 (1 : 100) showing positive staining in human Glioma tissue.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD44 antibody [EPR1013Y] (AB51037)
Immunohistochemical analysis of paraffin-embedded human cervical cancer tissue labeling CD44 with ab51037 at 1/100 dilution followed by goat anti-rabbit IgG H&L (HRP) (ab97051, 1/500). The sample was counter stained with hematoxylin.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD44 antibody [EPR1013Y] (AB51037)
Immunohistochemical analysis of paraffin-embedded human pancreatic cancer tissue labeling CD44 with ab51037 at 1/100 dilution followed by goat anti-rabbit IgG H&L (HRP) (ab97051, 1/500). The sample was counter stained with hematoxylin.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD44 antibody [EPR1013Y] (AB51037)
Immunohistochemical analysis of paraffin-embedded human skin tissue labeling CD44 with ab51037 at 1/100 dilution followed by goat anti-rabbit IgG H&L (HRP) (ab97051, 1/500). The sample was counter stained with hematoxylin.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD44 antibody [EPR1013Y] (AB51037)
ab51037 (1 : 100) showing positive staining in human Breast carcinoma tissue.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD44 antibody [EPR1013Y] (AB51037)
Immunohistochemical analysis of paraffin-embedded human tonsil tissue labeling CD44 with ab51037 at 1/100 dilution followed by goat anti-rabbit IgG H&L (HRP) (ab97051, 1/500). The sample was counter stained with hematoxylin.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD44 antibody [EPR1013Y] (AB51037)
ab51037 (1 : 100) showing positive staining in human Thyroid gland carcinoma tissue.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- WB
Lab
Western blot - Anti-CD44 antibody [EPR1013Y] (AB51037)
Lanes 1 - 4 : Merged signal (red and green). Green - ab51037 observed at 80 kDa. Red - loading control, ab8245 (Mouse anti-GAPDH antibody [6C5]) observed at 37kDa.
ab51037 was shown to react with CD44 in wild-type HeLa cells in western blot. Loss of signal was observed when CD44 knockout sample was used. Wild-type HeLa and CD44 knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 3% milk in TBS-T (0.1% Tween®) before incubation with ab51037 and ab8245 (Mouse anti-GAPDH antibody [6C5]) overnight at 4°C at a 1 in 5000 dilution and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-CD44 antibody [EPR1013Y] (ab51037) at 1/5000 dilution
Lane 1:
Wild-type HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 20 µg
Lane 2:
CD44 knockout HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 20 µg
Lane 2:
Western blot - Human CD44 knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-cd44-knockout-hela-cell-line-ab262515'>ab262515</a>)
Lane 3:
A549 (Human lung carcinoma cell line) whole cell lysate at 20 µg
Lane 4:
LNCaP (Human prostate cancer cell line) whole cell lysate at 20 µg
Predicted band size: 81 kDa
Observed band size: 80 kDa
false
- WB
Lab
Western blot - Anti-CD44 antibody [EPR1013Y] (AB51037)
False colour image of Western blot : Anti-CD44 antibody [EPR1013Y] staining at 1/5000 dilution, shown in green; Mouse anti-Alpha Tubulin [DM1A] (ab7291) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab51037 was shown to bind specifically to CD44. A band was observed at 75-80 kDa in wild-type HeLa cell lysates with no signal observed at this size in CD44 knockout cell line ab262515 (knockout cell lysate ab263938). To generate this image, wild-type and CD44 knockout HeLa cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4°C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.
All lanes:
Western blot - Anti-CD44 antibody [EPR1013Y] (ab51037) at 1/5000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
CD44 knockout HeLa cell lysate at 20 µg
Lane 2:
Western blot - Human CD44 knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-cd44-knockout-hela-cell-line-ab262515'>ab262515</a>)
Lane 3:
A549 cell lysate at 20 µg
Lane 4:
LNCaP cell lysate at 20 µg
Predicted band size: 81 kDa
Observed band size: 75-80 kDa
false
- WB
Lab
Western blot - Anti-CD44 antibody [EPR1013Y] (AB51037)
Blocking and diluting buffer 5% NFDM/TBST
The expression of CD44 in MCF-7 is low (PMID : 25635866; PMID : 26005723). Jurkat does not express CD44 (PMID : 24127558).
All lanes:
Western blot - Anti-CD44 antibody [EPR1013Y] (ab51037) at 1/1000 dilution
Lane 1:
MCF-7 whole cell lysate at 10 µg
Lane 2:
Jurkat whole cell lysate at 10 µg
Lane 3:
MDA-MB-231 whole cell lysate at 10 µg
Lane 4:
HeLa whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 81 kDa
Observed band size: 81 kDa
false
Exposure time: 3min
- WB
Unknown
Western blot - Anti-CD44 antibody [EPR1013Y] (AB51037)
All lanes:
Western blot - Anti-CD44 antibody [EPR1013Y] (ab51037) at 1/5000 dilution
All lanes:
TF-1 cell lysate at 10 µg
Secondary
All lanes:
Goat anti-Rabbit HRP labeled. at 1/2000 dilution
Predicted band size: 81 kDa
Observed band size: 82 kDa
false
- OI-RD Scanning
Unknown
OI-RD Scanning - Anti-CD44 antibody [EPR1013Y] (AB51037)
We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.
Related conjugates and formulations (9)
-
HRP Anti-CD44 antibody [EPR1013Y]
-
Anti-CD44 antibody [EPR1013Y] - BSA and Azide free
-
603 Alexa Fluor® 568
Alexa Fluor® 568 Anti-CD44 antibody [EPR1013Y]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-CD44 antibody [EPR1013Y]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-CD44 antibody [EPR1013Y]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-CD44 antibody [EPR1013Y]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-CD44 antibody [EPR1013Y]
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-CD44 antibody [EPR1013Y]
-
Anti-CD44 antibody [EPR1013Y] - Low endotoxin, Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (177)
Recent publications for all applications. Explore the full list and refine your search
PloS one 20:e0330478 PubMed40839600
2025
Applications
Unspecified application
Species
Unspecified reactive species
Biomedicines 13: PubMed40722682
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cancer gene therapy 32:437-449 PubMed40089636
2025
Applications
Unspecified application
Species
Unspecified reactive species
Pharmaceuticals (Basel, Switzerland) 17: PubMed39458997
2024
Applications
Unspecified application
Species
Unspecified reactive species
BMC cancer 24:451 PubMed38605343
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of Nippon Medical School = Nippon Ika Daigaku zasshi 91:218-226 PubMed38233123
2024
Applications
Unspecified application
Species
Unspecified reactive species
Molecular systems biology 19:e11503 PubMed37602975
2023
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 24: PubMed37446144
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 14:350 PubMed37280198
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in molecular neuroscience 16:1119164 PubMed36998510
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com